Repligen Corporation
RGEN
$144.75
-$0.48-0.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.56% | 9.69% | -0.21% | -7.38% | -10.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.56% | 9.69% | -0.21% | -7.38% | -10.78% |
| Cost of Revenue | 8.42% | -7.35% | -3.16% | -7.35% | -11.29% |
| Gross Profit | -6.79% | 33.24% | 2.73% | -7.40% | -10.31% |
| SG&A Expenses | -33.70% | 36.13% | 33.05% | 8.56% | 7.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.46% | 8.70% | 10.36% | -1.52% | -4.64% |
| Operating Income | 63.74% | 16.26% | -69.43% | -65.73% | -40.85% |
| Income Before Tax | -2,170.13% | -110.10% | -63.75% | -80.09% | -96.48% |
| Income Tax Expenses | -125.87% | 91.07% | -35.26% | -87.60% | 330.23% |
| Earnings from Continuing Operations | -105.89% | -103.86% | -71.13% | -78.51% | -133.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -105.89% | -103.86% | -71.13% | -78.51% | -133.76% |
| EBIT | 63.74% | 16.26% | -69.43% | -65.73% | -40.85% |
| EBITDA | 36.26% | 22.14% | -37.01% | -27.51% | -21.85% |
| EPS Basic | -105.02% | -103.86% | -71.23% | -78.58% | -133.59% |
| Normalized Basic EPS | 21.58% | 60.16% | -62.67% | -74.25% | -34.99% |
| EPS Diluted | -106.89% | -103.90% | -71.43% | -78.11% | -134.54% |
| Normalized Diluted EPS | 21.58% | 62.81% | -62.28% | -73.89% | -33.17% |
| Average Basic Shares Outstanding | 0.43% | 0.44% | 0.32% | 0.36% | 0.49% |
| Average Diluted Shares Outstanding | 0.43% | -1.63% | -0.75% | -0.91% | -2.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |